Vitamin A cycle byproducts explain retinal damage and molecular changes thought to initiate retinal degeneration

Biol Open. 2021 Nov 15;10(11):bio058600. doi: 10.1242/bio.058600. Epub 2021 Nov 29.

Abstract

In the most prevalent retinal diseases, including Stargardt disease and age-related macular degeneration (AMD), byproducts of vitamin A form in the retina abnormally during the vitamin A cycle. Despite evidence of their toxicity, whether these vitamin A cycle byproducts contribute to retinal disease, are symptoms, beneficial, or benign has been debated. We delivered a representative vitamin A byproduct, A2E, to the rat's retina and monitored electrophysiological, histological, proteomic, and transcriptomic changes. We show that the vitamin A cycle byproduct is sufficient alone to damage the RPE, photoreceptor inner and outer segments, and the outer plexiform layer, cause the formation of sub-retinal debris, alter transcription and protein synthesis, and diminish retinal function. The presented data are consistent with the theory that the formation of vitamin A byproducts during the vitamin A cycle is neither benign nor beneficial but may be sufficient alone to cause the most prevalent forms of retinal disease. Retarding the formation of vitamin A byproducts could potentially address the root cause of several retinal diseases to eliminate the threat of irreversible blindness for millions of people.

Keywords: A2E; Age-related macular degeneration; Retina; Stargardt disease; Vitamin A.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Macular Degeneration
  • Rats
  • Retina / metabolism
  • Retinal Degeneration / genetics*
  • Retinal Pigment Epithelium / metabolism
  • Retinoids / metabolism*
  • Vitamin A / metabolism*

Substances

  • A2-E (N-retinylidene-N-retinylethanolamine)
  • Retinoids
  • Vitamin A